ESOPHAGOGASTRIC ADENOCARCINOMA

Clinical trials for ESOPHAGOGASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ESOPHAGOGASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1 Terminated 1

New drug shows promise for Tough-to-Treat stomach cancer

Disease control Completed

This study tested a drug called sacituzumab-govitecan in 58 people with advanced stomach cancer that had spread to other parts of the body. The drug targets a protein on cancer cells to deliver chemotherapy directly. The goal was to see if the drug could shrink tumors or slow the…

Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

ESOPHAGOGASTRIC ADENOCARCINOMA

Get alerted when new ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

New drug shows promise for Tough-to-Treat stomach cancer